CD40LG and Sepsis: Giamarellos-Bourboulis and colleagues demonstrated in 332 critically ill patients with SIRS that IgM levels in patients with severe sepsis progressing to septic shock remained stable in nonsurvivors, whereas IgM of survivors presented an early peak with a subsequent gradual decrease [25].